atogepant 10 mg

1 INDICATIONS AND USAGE QULIPTA is indicated for the preventive treatment of migraine in adults. QULIPTA is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults. ( 1 )

abbvie inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] off label use` `[4] pain` `[5] nausea` `[6] headache` `[7] toxicity to various agents` `[8] arthralgia` `[9] death` `[10] dyspnoea`

2 years ago

ROUND WHITE A 10

2 years ago

A 10 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied QULIPTA 10 mg is supplied as white to off-white, round biconvex tablets debossed with “A” and “10” on one side in the following packaging presentations: Bottle of 30, NDC: 0074-7095-30 QULIPTA 30 mg is supplied as white to off-white, oval biconvex tablets debossed with “A30” on one side in the following packaging presentations: Bottle of 30, NDC: 0074-7096-30 QULIPTA 60 mg is supplied as white to off-white, oval biconvex tablets debossed with “A60” on one side in the following packaging presentations: Bottle of 30, NDC: 0074-7094-30 16.2 Storage and Handling Store between 20°C and 25°C (68°F and 77°F): excursions permitted between 15°C and 30°C (59°F and 86°F) [ see USP Controlled Room Temperature ] .

More pills like ROUND A 10

Related Pills

belviq lorcaserin hydrochloride hemihydrate tablet

eisai inc.

bupropion hydrochloride tablet film coated extended release

par pharmaceutical, inc.

Bupropion Hydrochloride 24 HR Bupropion Hydrochloride 150 MG Extended Release Oral Tablet

Par Pharmaceutical, Inc.

Omeprazole 20 mg

Cadila Healthcare Limited

Omeprazole 20 mg

cadila healthcare limited

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site